Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.8B | 1.8B | 1.5B |
Cost of revenue | 1.2B | 1.4B | 1.4B | 1.1B |
Gross profit | 317.9M | 392.8M | 379.7M | 358.7M |
Operating expense | ||||
Research & development | 261.6M | 320.6M | 244.1M | 185.8M |
Selling general and admin | 89.4M | -164.7M | 214.7M | -41.6M |
Other operating expenses | 5.6M | 7.7M | 5.7M | 5.7M |
Operating income | -7.4M | 76.3M | 80.4M | 101.0M |
Non operating interest income | ||||
Income | 21.9M | 22.9M | 25.2M | 23.2M |
Expense | 65.0M | 78.7M | 83.6M | 102.6M |
Other income expense | — | — | — | — |
Pretax income | -87.6M | 175.3M | -117.0M | 53.6M |
Tax provision | -35.9M | -3.4M | -47.6M | 6.3M |
Net income | -51.7M | 178.7M | -69.4M | 47.3M |
Basic EPS | 0.0 | — | — | — |
Diluted EPS | 0.0 | — | — | — |
Basic average shares | 2.6B | — | — | — |
Diluted average shares | 2.6B | — | — | — |
EBITDA | 8.9M | 225.5M | 12.3M | 168.9M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |